Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy (W.P.C., P.K., S.E.N., W.C.Z.), School of Medicine (J.C.L., A.M.F., D.L.C.-P., W.R.B., L.V.L., V.L.B.-J., P.A.G.), Department of Biostatistics (H.Z., J.H.M.), Lineberger Comprehensive Cancer Center (D.L.C.-P., W.R.B., L.V.L., V.L.B.-J., P.A.G., W.C.Z.), Institute for Pharmacogenomics and Individualized Therapy (W.C.Z.), Carolina Center of Cancer Nanotechnology Excellence (W.C.Z.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; School of Pharmacy, Texas Tech University Health Sciences Center, St. Amarillo, Texas (N.M.L.-B.); and North Carolina Biomedical Innovation Network, Research Triangle Park, North Carolina (W.C.Z.).
J Pharmacol Exp Ther. 2013 Dec;347(3):599-606. doi: 10.1124/jpet.113.208801. Epub 2013 Sep 16.
As nanoparticles (NPs) are cleared via phagocytes of the mononuclear phagocyte system (MPS), we hypothesized that the function of circulating monocytes and dendritic cells (MO/DC) in blood can predict NP clearance (CL). We measured MO/DC phagocytosis and reactive oxygen species (ROS) production in mice, rats, dogs, and patients with refractory solid tumors. Pharmacokinetic studies of polyethylene glycol (PEG)-encapsulated liposomal doxorubicin (PEGylated liposomal doxirubicin [PLD]), CKD-602 (S-CKD602), and cisplatin (SPI-077) were performed at the maximum tolerated dose. MO/DC function was also evaluated in patients with recurrent epithelial ovarian cancer (EOC) administered PLD. Across species, a positive association was observed between cell function and CL of PEGylated liposomes. In patients with EOC, associations were observed between PLD CL and phagocytosis (R(2) = 0.43, P = 0.04) and ROS production (R(2) = 0.61, P = 0.008) in blood MO/DC. These findings suggest that probes of MPS function may help predict PEGylated liposome CL across species and PLD CL in patients with EOC.
由于纳米颗粒(NPs)通过单核吞噬细胞系统(MPS)中的吞噬细胞清除,我们假设循环单核细胞和树突状细胞(MO/DC)在血液中的功能可以预测 NP 清除(CL)。我们测量了小鼠、大鼠、狗和患有难治性实体瘤的患者的 MO/DC 吞噬作用和活性氧(ROS)产生。在最大耐受剂量下进行了聚乙二醇(PEG)包封的脂质体多柔比星(PEGylated liposomal doxirubicin [PLD])、CKD-602(S-CKD602)和顺铂(SPI-077)的药代动力学研究。还在接受 PLD 治疗的复发性上皮性卵巢癌(EOC)患者中评估了 MO/DC 功能。在所有物种中,细胞功能与 PEG 化脂质体的 CL 之间存在正相关。在 EOC 患者中,PLD CL 与血液 MO/DC 中的吞噬作用(R(2) = 0.43,P = 0.04)和 ROS 产生(R(2) = 0.61,P = 0.008)之间存在关联。这些发现表明,MPS 功能的探针可能有助于预测不同物种的 PEG 化脂质体 CL 和 EOC 患者的 PLD CL。